The mammary gland iodide transporter is expressed during lactation and in breast cancer

Nature Medicine

Volumn 6, Issue 8, 2000, Pages 871-878

  Tazebay, Uygar H ^a   Wapnir, Irene L ^c   Levy, Orlie ^a,d   Dohan, Orsolya ^a   Zuckier, Lionel S ^a   Zhao, Qing Hua ^a   Deng, Hou Fu ^a   Amenta, Peter S ^c   Fineberg, Susan ^b   Pestell, Richard G ^a   Carrasco, Nancy ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b MONTEFIORE MEDICAL CENTER   (United States)

^c ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^d PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; IODIDE; RADIOACTIVE IODINE; TUMOR MARKER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST ADENOCARCINOMA; BREAST CANCER; BREAST RECONSTRUCTION; HORMONAL REGULATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LACTATION; MOUSE; NONHUMAN; ONCOGENE RAS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCINTIGRAPHY; THYROID CANCER; THYROID GLAND; TRANSGENIC MOUSE;

AMINO ACID SEQUENCE; ANIMALS; BREAST; BREAST NEOPLASMS; CARRIER PROTEINS; FEMALE; GENE EXPRESSION; HORMONES; HUMANS; IODIDES; IODINE RADIOISOTOPES; LACTATION; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, EXPERIMENTAL; MEMBRANE PROTEINS; MICE; MICE, TRANSGENIC; OVARIECTOMY; PREGNANCY; RATS; SYMPORTERS;

ANIMALIA; MUS MUSCULUS;

EID: 0033835541     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/78630     Document Type: Article

References (42)

1. Carrasco, N. Iodide transport in the thyroid gland. Biochim. Biophys. Acta 1154, 65-82 (1993).
2. Dai, G., Levy, O. & Carrasco, N. Cloning and characterization of the thyroid iodide transporter. Nature 379, 458-460 (1996).
3. +/I symporter with an anti-COOH terminus antibody. Proc. Natl. Acad. Sci. USA 94, 5568-5573 (1997).
4. +/I Symporter (NIS): implications for its secondary structure model. J. Biol. Chem. 273, 22657-22663 (1998).
5. +/I symporter: mechanism, stoichiometry, and specificity. J. Biol. Chem. 272, 27230-27238 (1997).
6. Stubbe, P., Schulte, F.J. & Heidenmann, P. Iodine deficiency and brain development. Biblthca. Nutr. Dieta 38, 206-208 (1986).
7. Mountford, P.J, Coakley, A.J., Fleet, I.R., Hamon, M. & Heap, R.B. Transfer of radioiodide to milk and its inhibition. Nature 322, 600 (1986).
8. DeCroot, L.J. in Endocrinology (ed. DeGroot, I.J.) 821-833 (Grune & Stratton Inc., Orlando, 1989).
9. Werner & Ingbar's The Thyroid 8th edn. (eds. Braverman, L.E. & Utiger, R.D.) 295-316 (Lippincott Williams & Wilkins, Philadelphia, 2000).
10. 131I in milk and rain after Chernobyl. Nature 324, 308 (1986).
11. Hill, C.R., Adam, I., Anderson, W., Ott, R.J. & Sowby, F.D. Iodine-131 in human thyroids in Britain following Chernobyl. Nature 321, 655-656 (1986).
12. Balter, M. Chernobyl's cancer toll. Science 270, 1758-1759 (1995).
13. Mazzaferri, E.L. NCCN thyroid carcinoma practice guidelines: NCCN proceedings. Oncology 13, 391-442 (1999).
14. Greenlee, R.T., Murray, T., Bolden, S. & Wingo, P. Cancer statistics 2000. A Cancer Journal for Clinicians 50, 7-33 (2000).
15. 99mpertechnetate by the thyroid gland of the rat. Endocrinology 80, 337-344 (1967).
16. Spitzweg, C., Joba, W., Eisenmenger, W. & Heufelder, A.E. Analysis of human sodium iodide symporter gene expression in extrathyroidal tissues and cloning of its complementary deoxyribonucleic acids from salivary gland, mammary gland, and gastric mucosa. J. Clin. Endocrinol. Metab. 83, 1746-1751 (1998).
17. Wakerley, J.B., O'Neill, D.S. & ter Haar, M.B. Relationship between the suckling-induced release of oxytocin and prolactin in the urethane-anaesthetized lactating rat. J. Endocrinol. 76, 493-500 (1978).
18. Higuschi, T., Honda, K., Fukuoka, T., Negoro, H. & Wakabayashi, K. Release of oxytocin during suckling and parturition in rat. J. Endocrinol. 105, 339-346 (1985).
19. McCormack, J.T. & Greenwald, G.S. Progesterone and oestradiol-17-_ concentrations in the peripheral plasma during pregnancy in the mouse. J. Endocrinol. 62, 101-107 (1974).
20. Rosenblatt, J. S., Mayer, A. D. & Giordano, A. L. Hormonal basis during pregnancy for the onset of maternal behaviour in the rat. Psychoneuroendocrinol. 13, 29-46 (1988).
21. Sinn, E. et al. Co-expression of MMTV/V-Ha-ras and MMTV/c-myc genes in transgenic mice: synergistic actions of oncogenes in vivo. Cell 49, 465-475 (1987).
22. Guy, C.T. et al. Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease. Proc. Natl. Acad. Sci. USA 89, 10578-10582 (1992).
23. Hung, M. & Lau, Y. Basic science of HER-2/neu: a review. Semin. Oncol. 26, 51-59 (1999).
24. Slamon, D.J. et al. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235, 177-182 (1987).
25. Paterson, M.C. et al. Correlation between c-erbB-2 amplification and risk of recurrent disease in node-negative breast cancer. Cancer Res. 51, 556-567 (1991).
26. Siegel, P.M., Ryan, E.D., Cardiff, R.D. & Muller, W.J. Elevated expression of activated forms of neu/ErbB-2 and ErbB-3 are involved in the induction of mammary tumors in transgenic mice: implications for human breast cancer. EMBO J. 18, 2149-2164 (1999).
27. DiGiovanna M.P. Clinical significance of HER-2/neu overexpression. Principles and Practice of Oncology 13, 1-10 (1999).
28. Zingg, H.H. et al. in Vasopressin and Oxytocin, Advances in Experimental Medicine and Biology (eds. H.H. Zingg, Bourque, C.W. & Bichet, D.G.) 287-297 (Plenum, New York, 1998).
29. Ohno, M., Zannini, M., Levy, O., Carrasco, N. & DiLauro, R. The paired domain transcription factor Pax8 binds to the upstream enhancer of the rat sodium/iodide symporter gene and participates in both thyroid-specific and cAMP dependent transcription. Mol. Cell. Biol. 19, 2051-2060 (1999).
30. Dorrington, J. & Gore-Langton, R.E. Prolactin inhibits oestrogen synthesis in the ovary. Nature 290, 600-602 (1981).
31. Gitay-Goren, H., Lindenbaum, E.S. & Kraiem, Z. Prolactin inhibits hCG-stimulated steroidogenesis and cAMP accumulation, possibly by increasing phosphodiesterase activity, in rat granulosa cell cultures. Mol. Cell. Endocrinol. 61, 69-76 (1989).
32. Krasnow, J.S., Hickey, G.J. & Richards, J.S. Regulation of aromatase mRNA and estradiol biosynthesis in rat ovarian granulosa and luteal cells by prolactin. Mol. Endocrinol. 4, 13-21 (1990).
33. Villanueva, L.A., Mendez, I., Ampuero, S. & Larrea, F. The prolactin inhibition of follicle-stimulating hormone-induced aromatase activity in cultured rat granulosa cells is in part tyrosine kinase and protein kinase-C dependent. Mol. Hum. Reprod. 2, 725-731 (1996).
34. Mattheij, J.A.M., Kuipers, M.A.C., Swarts, J.J.M. & Verstijnen, C.P.H.J. Intraperitonal infusion of EDTA in the rat blocks completely the prolactin rise in the plasma during suckling. Horm. Res. 16, 219-229 (1982).
35. Grazzini, E., Guillon, G., Mouillac, B. & Zingg, H. H. Inhibition of oxytocin receptor function by direct binding of progesterone. Nature 392, 509-512 (1998).
36. Fitzgerald, P.J. & Foote, F.W. Jr. The function of various types of thyroid carcinoma as revealed by the radioautographic demonstration of radioactive iodine. J. Clin. Endocrinol. 9, 1153-1170 (1949).
37. Pochin, E.E., Cunningham, R.M. & Hilton, G. Quantitative measurements of radioiodine retention in thyroid carcinoma. J. Clin. Endocrinol. Metab. 14, 1300-1308 (1954).
38. Valenta, L. Metastatic thyroid carcinoma in man concentrating iodide without organification. J. Clin. Endocrinol. 26, 1317-1324 (1966).
39. 99mTc-pertechnetate scintigraphy as an aid in the diagnosis of breast masses. Radiology 106, 441-444 (1973).
40. Smanik, P.A. et al. Cloning of the human sodium iodide symporter. Bioch. Biophys. Res. Commun. 226, 339-345 (1996).
41. Carrasco, N., Herzlinger, D., Danho, W. & Kaback, H.R. Preparation of monoclonal antibodies against the lac permease of Escherichia coli. Methods Enzymol. 125, 453-467 (1986).
42. +/I symport activity is present in membrane vesicles from thyrotropin-deprived non-l-transporting cultured thyroid cells. Proc. Natl. Acad. Sci. USA 91, 3789-3793 (1994).